BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24598658)

  • 21. [Synergistic effects of arsenic trioxide and proteasome inhibitor bortezomib on apoptosis induction in Raji cell line].
    He Y; Yang JM; Wang JM; Zhou H; Lü SQ; Hu XX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):794-8. PubMed ID: 18718063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of mTOR Inhibitor Rapamycin on Burkitt's Lymphoma Cells].
    Zhou LH; Zhu XP; Xiao HF; Xin PL; Li CT
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1397-1405. PubMed ID: 29070114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Rituximab-mediated sensitization of B-NHL cell lines to apoptosis induced by gemcitabine and Navelbine in vitro].
    Zhang HY; Chen HT; Peng PJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):873-6. PubMed ID: 20723291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of the effects of gemcitabine against pancreatic cancer by oridonin via the mitochondrial caspase-dependent signaling pathway.
    Liu DL; Bu HQ; Jin HM; Zhao JF; Li Y; Huang H
    Mol Med Rep; 2014 Dec; 10(6):3027-34. PubMed ID: 25242370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.
    Liu H; Zang C; Emde A; Planas-Silva MD; Rosche M; Kühnl A; Schulz CO; Elstner E; Possinger K; Eucker J
    Eur J Pharmacol; 2008 Sep; 591(1-3):43-51. PubMed ID: 18588872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Honokiol Is a Potential Therapeutic Agent and Has a Synergistic Effect With 5-FU in Human Urothelial Cell Carcinoma Cells.
    Lee MY; Shi CS; Hsu YC; Huang KJ; Chen SH; Zhao PW; Chung HC; Huang YC; Lee YR
    Anticancer Res; 2019 Dec; 39(12):6555-6565. PubMed ID: 31810921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy.
    Huang KJ; Kuo CH; Chen SH; Lin CY; Lee YR
    J Cell Mol Med; 2018 Mar; 22(3):1894-1908. PubMed ID: 29363886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aspirin inhibits proliferation of gemcitabine-resistant human pancreatic cancer cells and augments gemcitabine-induced cytotoxicity.
    Ou YQ; Zhu Wb; Li Y; Qiu PX; Huang YJ; Xie J; He SM; Zheng XK; Leng TD; Xu D; Yan GM
    Acta Pharmacol Sin; 2010 Jan; 31(1):73-80. PubMed ID: 19966835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pristimerin causes G1 arrest, induces apoptosis, and enhances the chemosensitivity to gemcitabine in pancreatic cancer cells.
    Wang Y; Zhou Y; Zhou H; Jia G; Liu J; Han B; Cheng Z; Jiang H; Pan S; Sun B
    PLoS One; 2012; 7(8):e43826. PubMed ID: 22952775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Honokiol induces autophagy and apoptosis of osteosarcoma through PI3K/Akt/mTOR signaling pathway.
    Li Z; Dong H; Li M; Wu Y; Liu Y; Zhao Y; Chen X; Ma M
    Mol Med Rep; 2018 Feb; 17(2):2719-2723. PubMed ID: 29207060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Honokiol augments the anti-cancer effects of oxaliplatin in colon cancer cells.
    Hua H; Chen W; Shen L; Sheng Q; Teng L
    Acta Biochim Biophys Sin (Shanghai); 2013 Sep; 45(9):773-9. PubMed ID: 23786838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Down-regulation of c-Src/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells.
    Park EJ; Min HY; Chung HJ; Hong JY; Kang YJ; Hung TM; Youn UJ; Kim YS; Bae K; Kang SS; Lee SK
    Cancer Lett; 2009 May; 277(2):133-40. PubMed ID: 19135778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination therapy with gossypol reveals synergism against gemcitabine resistance in cancer cells with high BCL-2 expression.
    Wong FY; Liem N; Xie C; Yan FL; Wong WC; Wang L; Yong WP
    PLoS One; 2012; 7(12):e50786. PubMed ID: 23226540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study on effect and mechanism of Honokiol enhancing tumor necrosis factor-related apoptosis inducing ligand against hepatocellular carcinoma HepG2 cells via activating JNK signaling pathway].
    Xiao G; Yang R; Dang L; Dong CL
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jun; 26(6):441-445. PubMed ID: 30317758
    [No Abstract]   [Full Text] [Related]  

  • 35. Downregulation of Sp1 is involved in honokiol-induced cell cycle arrest and apoptosis in human malignant pleural mesothelioma cells.
    Chae JI; Jeon YJ; Shim JH
    Oncol Rep; 2013 Jun; 29(6):2318-24. PubMed ID: 23525508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. pERK1/2 silencing sensitizes pancreatic cancer BXPC-3 cell to gemcitabine-induced apoptosis via regulating Bax and Bcl-2 expression.
    Wang M; Lu X; Dong X; Hao F; Liu Z; Ni G; Chen D
    World J Surg Oncol; 2015 Feb; 13():66. PubMed ID: 25880226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Honokiol enhances paclitaxel efficacy in multi-drug resistant human cancer model through the induction of apoptosis.
    Wang X; Beitler JJ; Wang H; Lee MJ; Huang W; Koenig L; Nannapaneni S; Amin AR; Bonner M; Shin HJ; Chen ZG; Arbiser JL; Shin DM
    PLoS One; 2014; 9(2):e86369. PubMed ID: 24586249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors.
    Leeman-Neill RJ; Cai Q; Joyce SC; Thomas SM; Bhola NE; Neill DB; Arbiser JL; Grandis JR
    Clin Cancer Res; 2010 May; 16(9):2571-9. PubMed ID: 20388852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Honokiol, a natural therapeutic candidate, induces apoptosis and inhibits angiogenesis of ovarian tumor cells.
    Li Z; Liu Y; Zhao X; Pan X; Yin R; Huang C; Chen L; Wei Y
    Eur J Obstet Gynecol Reprod Biol; 2008 Sep; 140(1):95-102. PubMed ID: 18440692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic effect of honokiol and 5-fluorouracil on apoptosis of oral squamous cell carcinoma cells.
    Ji N; Jiang L; Deng P; Xu H; Chen F; Liu J; Li J; Liao G; Zeng X; Lin Y; Feng M; Li L; Chen Q
    J Oral Pathol Med; 2017 Mar; 46(3):201-207. PubMed ID: 27465776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.